Correlative analysis between two commercially available post-prostatectomy genomic tests
Sign Up to like & getrecommendations! Published in 2021 at "Prostate Cancer and Prostatic Diseases"
DOI: 10.1038/s41391-020-00305-0
Abstract: Background Multiple genomic tests are available following radical prostatectomy (RP), however, there is a lack of head-to-head evidence for these tests. We sought to compare the performance of two genomic tests in predicting post-RP oncological… read more here.
Keywords: genomic tests; mccp; prostatectomy; cohort ... See more keywords
Utilisation of subsidised genetic and genomic testing in a publicly funded healthcare system 2014–2023
Sign Up to like & getrecommendations! Published in 2025 at "European Journal of Human Genetics"
DOI: 10.1038/s41431-025-01801-4
Abstract: The Australian government subsidises medical services, including several genetic and genomic tests, through a federal funding scheme. We explore trends and variation in the utilisation of the publicly funded genetic and genomic tests over the… read more here.
Keywords: utilisation; genetic genomic; 2014 2023; publicly funded ... See more keywords
Using Cost-Effectiveness Analysis to Quantify the Value of Genomic-Based Diagnostic Tests: Recommendations for Practice and Research.
Sign Up to like & getrecommendations! Published in 2017 at "Genetic testing and molecular biomarkers"
DOI: 10.1089/gtmb.2017.0105
Abstract: AIMS New sequencing technologies allow increased opportunities to use genomic-based diagnostic tests (genomic tests) in routine clinical practice, which will impact healthcare budgets and patients' outcomes. This article aims to generate a list of recommendations… read more here.
Keywords: genomic tests; research; genomic based; diagnostic tests ... See more keywords
Insurance coverage for genomic tests
Sign Up to like & getrecommendations! Published in 2018 at "Science"
DOI: 10.1126/science.aas9268
Abstract: On 16 March, the Centers for Medicare and Medicaid Services (CMS) announced that Medicare will cover Food and Drug Administration (FDA)–approved or cleared genomic tests that encompass broad gene panels for advanced cancer patients ([… read more here.
Keywords: genomic tests; insurance coverage; coverage genomic;
Candidates of Genomic Tests in HR+/HER2- Breast Cancer Patients With 1-2 Positive Sentinel Lymph Node Without Axillary Lymph Node Dissection: Analysis From Multicentric Cohorts
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.722325
Abstract: Background The genomic tests such as the MammaPrint and Oncotype DX test are being gradually applied for hormone receptor positive/HER-2 negative (HR+/HER2-) breast cancer patients with up to three positive axillary lymph nodes (ALNs). The… read more here.
Keywords: genomic tests; breast cancer; patients positive; lymph node ... See more keywords
Integrative Genomic Tests in Clinical Oncology
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms232113129
Abstract: Many clinical decisions in oncology practice rely on the presence or absence of an alteration in a single genetic locus, be it a pathogenic variant in a hereditary cancer gene or activating mutation in a… read more here.
Keywords: oncology; tests clinical; genomic tests; integrative genomic ... See more keywords